These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3948914

  • 1. Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema.
    Hwang SB, Lam MH, Li CL, Shen TY.
    Eur J Pharmacol; 1986 Jan 14; 120(1):33-41. PubMed ID: 3948914
    [Abstract] [Full Text] [Related]

  • 2. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB, Li CL, Lam MH, Shen TY.
    Lab Invest; 1985 Jun 14; 52(6):617-30. PubMed ID: 3925239
    [Abstract] [Full Text] [Related]

  • 3. A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat.
    Goldenberg MM, Meurer RD.
    Prostaglandins; 1984 Aug 14; 28(2):271-8. PubMed ID: 6505225
    [Abstract] [Full Text] [Related]

  • 4. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.
    Doebber TW, Wu MS, Robbins JC, Choy BM, Chang MN, Shen TY.
    Biochem Biophys Res Commun; 1985 Mar 29; 127(3):799-808. PubMed ID: 2985058
    [Abstract] [Full Text] [Related]

  • 5. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X.
    Int J Tissue React; 1985 Mar 29; 7(5):339-43. PubMed ID: 2997065
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X, Han GQ, Li RZ.
    Proc Natl Acad Sci U S A; 1985 Feb 29; 82(3):672-6. PubMed ID: 2983307
    [Abstract] [Full Text] [Related]

  • 7. trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
    Hwang SB, Lam MH, Biftu T, Beattie TR, Shen TY.
    J Biol Chem; 1985 Dec 15; 260(29):15639-45. PubMed ID: 2999126
    [Abstract] [Full Text] [Related]

  • 8. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D, Chignard M, Korth R, Le Couedic JP, Norel X, Spinnewyn B, Braquet P, Benveniste J.
    Eur J Pharmacol; 1986 Apr 16; 123(2):197-205. PubMed ID: 3086108
    [Abstract] [Full Text] [Related]

  • 9. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM, Man RY.
    Br J Pharmacol; 1991 Dec 16; 104(4):933-7. PubMed ID: 1810604
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of the effect of CV-6209, a specific PAF-antagonist, on rat paw edema caused by different phlogogen agents.
    Merlos M, Gómez LA, Vericat L, García-Rafanell J, Forn J.
    Pharmacology; 1990 Dec 16; 40(4):211-7. PubMed ID: 1697076
    [Abstract] [Full Text] [Related]

  • 11. Species difference in the specific receptors of platelet activating factor.
    Hwang SB, Lam MH.
    Biochem Pharmacol; 1986 Dec 15; 35(24):4511-8. PubMed ID: 3024653
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist.
    Montrucchio G, Alloatti G, Mariano F, Tetta C, Emanuelli G, Camussi G.
    Int J Tissue React; 1986 Dec 15; 8(6):497-504. PubMed ID: 3025124
    [Abstract] [Full Text] [Related]

  • 14. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse.
    Henriques MG, Weg VB, Martins MA, Silva PM, Fernandes PD, Cordeiro RS, Vargaftig BB.
    Br J Pharmacol; 1990 Jan 15; 99(1):164-8. PubMed ID: 2331569
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr.
    Ko FN, Wu TS, Liou MJ, Huang TF, Teng CM.
    Eur J Pharmacol; 1992 Jul 21; 218(1):129-35. PubMed ID: 1327822
    [Abstract] [Full Text] [Related]

  • 17. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG, Chao W, Levine BA, Olson MS.
    Am J Pathol; 1990 Dec 21; 137(6):1501-8. PubMed ID: 1701964
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema.
    Caruso A, Cutuli VM, De Bernardis E, Leonardi G, Amico-Roxas M.
    Pharmacol Res; 1995 Jan 21; 31(1):67-72. PubMed ID: 7784308
    [Abstract] [Full Text] [Related]

  • 20. Platelet involvement in rat paw edema induced by 2-methoxy-PAF.
    Silva PM, Cordeiro RS, Martins MA, Henriques MG, Vargaftig BB.
    Inflammation; 1986 Dec 21; 10(4):393-401. PubMed ID: 3793206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.